{"schema_version":"secwatch.filing_event.v1","accession":"0001818382-26-000011","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2026-09-28T20:05:14+00:00","discovered_at":"2026-09-28T20:06:04.188091+00:00","generated_at":"2026-10-12T13:34:48.702213+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Humacyte adds Scott Coward and Paul Kuznik to board ahead of planned ATEV dialysis launch","bullets":["Board appointed Scott Coward (Class I, term to 2028, Audit Committee) and Paul Kuznik (Class II, term to 2029, Commercial Committee) on September 22, 2026.","Coward was EVP, Chief Legal Officer and CAO of Exact Sciences from January 2015 to December 2022 and led the Genomic Health integration; he has been an attorney at K&L Gates since July 2026.","Kuznik was CEO of Bolton Medical (2015-2018) through its acquisition by Terumo, then President of Terumo Aortic North America from 2020 to 2023.","Each director receives a $50,000 annual cash retainer, $5,000 per committee, and an option for 125,000 HUMA shares under the non-employee director program.","CEO Laura Niklason cited the additions as Humacyte expands the Symvess launch and prepares the ATEV commercial launch for dialysis access."],"urls":{"canonical":"https://secwatch.observer/filing/0001818382-26-000011","json":"https://secwatch.observer/filing/0001818382-26-000011.json","markdown":"https://secwatch.observer/filing/0001818382-26-000011.md","text":"https://secwatch.observer/filing/0001818382-26-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000181838226000011/0001818382-26-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000181838226000011/huma-20260922.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:34:48.702213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}